Clinical Trial Update: The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency [Phase 4]

View source ↗

Summary

This update describes a Phase 4 clinical trial comparing low-dose versus high-dose intravenous ferric derisomaltose in patients with chronic heart failure and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency

Drugs mentioned

• Ferric derisomaltose (ferric derisomaltose)

Snippet

Sponsor: China-Japan Friendship Hospital | Conditions: Heart Failure, Iron Deficiency | Phase 4 | Status: RECRUITING